Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $3.0300 (-2.57%) ($3.0300 - $3.0300) on Mon. Feb. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.63% (three month average) | RSI | 33 | Latest Price | $3.0300(-2.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.9% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(86%) IWO(84%) SKYY(83%) ARKG(82%) QQQ(82%) | Factors Impacting CGEN price | CGEN will decline at least -1.815% in a week (0% probabilities). VIXM(-75%) VXX(-56%) UUP(-31%) EDOC(-16%) GLD(-10%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.815% (StdDev 3.63%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-10.95(-461.39%) | Resistance Level | $3.38 | 5 Day Moving Average | $3.15(-3.81%) | 10 Day Moving Average | $3.2(-5.31%) | 20 Day Moving Average | $3.38(-10.36%) | To recent high | -44.4% | To recent low | 0% | Market Cap | $251m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |